Reports indicate that Trump is expected to sign an executive order as early as next Monday to reclassify marijuana from Schedule I to the more lenient Schedule III drug category, which is expected to take effect early next year. Following the news, cannabis stocks surged significantly during Friday's trading session. Cannabis producer Tilray Brands soared by 44%, while Canopy Growth skyrocketed by 53%.